Premium
Intestinal transplantation for the treatment of neoplastic disease
Author(s) -
Moon Jang I.,
Selvaggi Gennaro,
Nishida Seigo,
Levi David M.,
Kato Tomoaki,
Ruiz Philip,
Bejarano Pablo,
Madariaga Juan R.,
Tzakis Andreas G.
Publication year - 2005
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.20416
Subject(s) - medicine , surgery , transplantation , adenocarcinoma , neoplasm , disease , neuroendocrine tumors , thrombosis , medical record , cancer , pathology
Background Authors reviewed single center experience of intestinal transplantation for treatment of intra‐abdominal neoplastic disease. Methods There were 25 auto‐ or allograft transplantations in 21 patients; desmoid tumor (14), neuroendocrine tumor (2), adenocarcinoma (2), hemangioma (1), lymphoma (1), and solid pseudopapillary tumor (1). Medical records were reviewed for cause of graft loss and mortality, recurrent neoplasm, and quality of life. Survival was analyzed using Kaplan–Meier method. Results There were 11 graft losses; mortality with functioning graft (6), ischemic necrosis (2), acute or chronic rejection (2), and arterial thrombosis (1) during 38 months of mean follow‐up. Seven patients died because of recurrent neoplasm and transplant related complications. Six patients experienced recurrent disease; three desmoid tumor (3/14), two adenocarcinoma (2/2), and one neuroendocrine tumor (1/2). Recurrent desmoid tumors were successfully treated with simple excision. Patient and graft survival in the desmoid tumor are 69.2% and 50.0% at 5 years after transplant. Among 14 survivors, 2 need parenteral nutrition or intravenous hydration. Twelve patients are working full time. Conclusions Intestinal transplantation is a reasonable life‐saving treatment for catastrophic intra‐abdominal neoplastic diseases. J. Surg. Oncol. 2005;92:284–291. © 2005 Wiley‐Liss, Inc.